Transcripts Astellas Pharma Inc. Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 14:49:28 17/05/2024 BST			5-day change	1st Jan Change
8.472 ^EUR	-3.73%		-3.75%	-22.84%

05-16	Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	DJ
05-08	Astellas Unveils New, State-Of-The-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor	CI

Transcript : Astellas Pharma Inc., 2024 Earnings Call, Apr 25, 2024	04-25
Transcript : Astellas Pharma Inc. - Special Call	02-21
Transcript : Astellas Pharma Inc., Q3 2024 Earnings Call, Feb 05, 2024	02-05
Transcript : Astellas Pharma Inc. - Special Call	11-05
Transcript : Astellas Pharma Inc., Q2 2024 Earnings Call, Nov 01, 2023	11-01
Transcript : Astellas Pharma Inc., Q1 2024 Earnings Call, Aug 01, 2023	01/08/23
Transcript : Astellas Pharma Inc., IVERIC bio, Inc. - M&A Call	01/05/23
Transcript : Astellas Pharma Inc., 2023 Earnings Call, Apr 27, 2023	27/04/23
Transcript : Astellas Pharma Inc. - Special Call	27/03/23
Transcript : Astellas Pharma Inc. - Special Call	17/02/23
Transcript : Astellas Pharma Inc., Q3 2023 Earnings Call, Feb 06, 2023	06/02/23
Transcript : Astellas Pharma Inc. - Special Call	09/12/22
Transcript : Astellas Pharma Inc., Q2 2023 Earnings Call, Oct 31, 2022	31/10/22
Transcript : Astellas Pharma Inc. - Special Call	17/10/22
Transcript : Astellas Pharma Inc., Q1 2023 Earnings Call, Aug 01, 2022	01/08/22
Transcript : Astellas Pharma Inc., 2022 Earnings Call, Apr 27, 2022	27/04/22
Transcript : Astellas Pharma Inc. - Special Call	09/03/22
Transcript : Astellas Pharma Inc. - Special Call	28/02/22
Transcript : Astellas Pharma Inc., Q3 2022 Earnings Call, Feb 02, 2022	02/02/22
Astellas Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	02/02/22	CI

No results for this search